Skip to main content
Top
Published in: Heart and Vessels 9/2018

01-09-2018 | Original Article

Persistence of an iatrogenic atrial septal defect after a second-generation cryoballoon ablation of atrial fibrillation

Authors: Tomonori Watanabe, Shinsuke Miyazaki, Takatsugu Kajiyama, Sadamitsu Ichijo, Takamitsu Takagi, Miyako Igarashi, Hiroaki Nakamura, Hiroshi Taniguchi, Hitoshi Hachiya, Yoshito Iesaka

Published in: Heart and Vessels | Issue 9/2018

Login to get access

Abstract

Persistent iatrogenic atrial septal defects (iASDs) can be observed after intervention requiring a left atria (LA) access, including pulmonary vein isolation (PVI) of atrial fibrillation (AF). We investigated the incidence of iASDs post-second-generation cryoballoon ablation and the pre-procedural predictors. Eighty-three paroxysmal AF patients underwent PVI using second-generation cryoballoons. The LA was accessed with single 15-Fr steerable sheaths following a radiofrequency transseptal puncture, and the iASD was evaluated with transthoracic echocardiography (TTE), a median of 9.3 (7.1–13.3) months post-procedure. All patients underwent pre-procedural contrast-enhanced multi-detector computed tomography (CT) to evaluate the LA and PV anatomy. iASDs were detected by TTE in 7 (8.4%) patients, a median of 15.5 (6.8–17.3) months post-procedure. Patients with iASDs had significantly larger LA volumes and smaller atrial septal angles, defined as the angle between the atrial septum and sagittal line on the horizontal section at the height of the fossa ovalis, which could be the transseptal puncture site measured on CT, and more likely hypertension than those without. Multivariate analyses revealed that the atrial septal angle was the sole predictor of iASDs [odds ratio 0.764, 95% confidence interval (CI) 0.624–0.935, p = 0.009], and the optimal cut-off value was 57.5° (sensitivity 85.7%, specificity 88.2%, 95% CI 0.873–0.995, p < 0.0001). Patients with iASDs were asymptomatic and had no adverse clinical events during a 17.7 (14.4–25.8) month median follow-up. iASDs were still detectable in 8.4% of patients a median of 15.5 months after the second-generation CB ablation, and the atrial septal angle might aid in predicting persistent iASDs.
Appendix
Available only for authorised users
Literature
1.
go back to reference Haïssaguerre M, Jaïs P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Métayer P, Clémenty J (1998) Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339:659–666CrossRefPubMed Haïssaguerre M, Jaïs P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Métayer P, Clémenty J (1998) Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339:659–666CrossRefPubMed
2.
go back to reference Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D, Heart Rhythm Society Task Force on Catheter and Surgical Ablation of Atrial Fibrillation (2012) 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm 9:632–696CrossRefPubMedPubMedCentral Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D, Heart Rhythm Society Task Force on Catheter and Surgical Ablation of Atrial Fibrillation (2012) 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm 9:632–696CrossRefPubMedPubMedCentral
3.
go back to reference Packer DL, Kowal RC, Wheelan KR, Irwin JM, Champagne J, Guerra PG, Dubuc M, Reddy V, Nelson L, Holcomb RG, Lehmann JW, Ruskin JN, Cryoablation Investigators STOPAF (2013) Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol 61:1713–1723CrossRefPubMed Packer DL, Kowal RC, Wheelan KR, Irwin JM, Champagne J, Guerra PG, Dubuc M, Reddy V, Nelson L, Holcomb RG, Lehmann JW, Ruskin JN, Cryoablation Investigators STOPAF (2013) Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol 61:1713–1723CrossRefPubMed
4.
go back to reference Kuck KH, Brugada J, Fürnkranz A, Metzner A, Ouyang F, Chun KR, Elvan A, Arentz T, Bestehorn K, Pocock SJ, Albenque JP, Tondo C, FIRE AND ICE Investigators (2016) Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med 374:2235–2245CrossRefPubMed Kuck KH, Brugada J, Fürnkranz A, Metzner A, Ouyang F, Chun KR, Elvan A, Arentz T, Bestehorn K, Pocock SJ, Albenque JP, Tondo C, FIRE AND ICE Investigators (2016) Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med 374:2235–2245CrossRefPubMed
5.
go back to reference Hammerstingl C, Lickfett L, Jeong KM, Troatz C, Wedekind JA, Tiemann K, Lüderitz B, Lewalter T (2006) Persistence of iatrogenic atrial septal defect after pulmonary vein isolation—an underestimated risk? Am Heart J 152:362CrossRefPubMed Hammerstingl C, Lickfett L, Jeong KM, Troatz C, Wedekind JA, Tiemann K, Lüderitz B, Lewalter T (2006) Persistence of iatrogenic atrial septal defect after pulmonary vein isolation—an underestimated risk? Am Heart J 152:362CrossRefPubMed
6.
go back to reference Rillig A, Meyerfeldt U, Birkemeyer R, Treusch F, Kunze M, Jung W (2008) Persistent iatrogenic atrial septal defect after pulmonary vein isolation: incidence and clinical implications. J Interv Card Electrophysiol 22:177–181CrossRefPubMed Rillig A, Meyerfeldt U, Birkemeyer R, Treusch F, Kunze M, Jung W (2008) Persistent iatrogenic atrial septal defect after pulmonary vein isolation: incidence and clinical implications. J Interv Card Electrophysiol 22:177–181CrossRefPubMed
7.
go back to reference McGinty PM, Smith TW, Rogers JH (2011) Transseptal left heart catheterization and the incidence of persistent iatrogenic atrial septal defects. J Interv Cardiol 24:254–263CrossRefPubMed McGinty PM, Smith TW, Rogers JH (2011) Transseptal left heart catheterization and the incidence of persistent iatrogenic atrial septal defects. J Interv Cardiol 24:254–263CrossRefPubMed
8.
go back to reference Singh SM, Douglas PS, Reddy VY (2011) The incidence and long-term clinical outcome of iatrogenic atrial septal defects secondary to transseptal catheterization with a 12F transseptal sheath. Circ Arrhythm Electrophysiol 4:166–171CrossRefPubMed Singh SM, Douglas PS, Reddy VY (2011) The incidence and long-term clinical outcome of iatrogenic atrial septal defects secondary to transseptal catheterization with a 12F transseptal sheath. Circ Arrhythm Electrophysiol 4:166–171CrossRefPubMed
9.
go back to reference Chan NY, Choy CC, Lau CL, Lo YK, Chu PS, Yuen HC, Mok NS, Tsui PT, Lau ST (2011) Persistent iatrogenic atrial septal defect after pulmonary vein isolation by cryoballoon: an under-recognized complication. Europace 13:1406–1410CrossRefPubMed Chan NY, Choy CC, Lau CL, Lo YK, Chu PS, Yuen HC, Mok NS, Tsui PT, Lau ST (2011) Persistent iatrogenic atrial septal defect after pulmonary vein isolation by cryoballoon: an under-recognized complication. Europace 13:1406–1410CrossRefPubMed
10.
go back to reference Cronin EM, Collier P, Wazni OM, Griffin BP, Jaber WA, Saliba WI (2013) Persistence of atrial septal defect after cryoballoon ablation of atrial fibrillation. J Am Coll Cardiol 62:1491–1492CrossRefPubMed Cronin EM, Collier P, Wazni OM, Griffin BP, Jaber WA, Saliba WI (2013) Persistence of atrial septal defect after cryoballoon ablation of atrial fibrillation. J Am Coll Cardiol 62:1491–1492CrossRefPubMed
11.
go back to reference Sieira J, Chierchia GB, Di Giovanni G, Conte G, De Asmundis C, Sarkozy A, Droogmans S, Baltogiannis G, Saitoh Y, Ciconte G, Levinstein M, Brugada P (2014) One year incidence of iatrogenic atrial septal defect after cryoballoon ablation for atrial fibrillation. J Cardiovasc Electrophysiol 25:11–15CrossRefPubMed Sieira J, Chierchia GB, Di Giovanni G, Conte G, De Asmundis C, Sarkozy A, Droogmans S, Baltogiannis G, Saitoh Y, Ciconte G, Levinstein M, Brugada P (2014) One year incidence of iatrogenic atrial septal defect after cryoballoon ablation for atrial fibrillation. J Cardiovasc Electrophysiol 25:11–15CrossRefPubMed
12.
go back to reference Coulombe N, Paulin J, Su W (2013) Improved in vivo performance of second-generation cryoballoon for pulmonary vein isolation. J Cardiovasc Electrophysiol 24:919–925CrossRefPubMed Coulombe N, Paulin J, Su W (2013) Improved in vivo performance of second-generation cryoballoon for pulmonary vein isolation. J Cardiovasc Electrophysiol 24:919–925CrossRefPubMed
13.
go back to reference Martins RP, Hamon D, Césari O, Behaghel A, Behar N, Sellal JM, Daubert JC, Mabo P, Pavin D (2014) Safety and efficacy of a second-generation cryoballoon in the ablation of paroxysmal atrial fibrillation. Heart Rhythm 11:386–393CrossRefPubMed Martins RP, Hamon D, Césari O, Behaghel A, Behar N, Sellal JM, Daubert JC, Mabo P, Pavin D (2014) Safety and efficacy of a second-generation cryoballoon in the ablation of paroxysmal atrial fibrillation. Heart Rhythm 11:386–393CrossRefPubMed
14.
go back to reference Yousuf MA, Haq S, O’Donnell RE, Attari M (2015) Hemodynamically significant atrial septal defect after atrial fibrillation ablation: a hole to remember. Heart Rhythm 12:1987–1989CrossRefPubMed Yousuf MA, Haq S, O’Donnell RE, Attari M (2015) Hemodynamically significant atrial septal defect after atrial fibrillation ablation: a hole to remember. Heart Rhythm 12:1987–1989CrossRefPubMed
15.
go back to reference Wang JK, Chiu SN, Lin MT, Chen CA, Lu CW, Wu MH (2017) Mid-to-long-term follow-up results of transcatheter closure of atrial septal defect in patients older than 40 years. Heart Vessels 32:467–473CrossRefPubMed Wang JK, Chiu SN, Lin MT, Chen CA, Lu CW, Wu MH (2017) Mid-to-long-term follow-up results of transcatheter closure of atrial septal defect in patients older than 40 years. Heart Vessels 32:467–473CrossRefPubMed
16.
go back to reference Murakami T, Nakazawa G, Horinouchi H, Torii S, Ijichi T, Ohno Y, Amino M, Shinozaki N, Ogata N, Yoshimachi F, Yoshioka K, Ikari Y (2017) Transcatheter closure of atrial septal defect protects from pulmonary edema: septal occluder device gradually reduces LR shunt. Heart Vessels 32:101–104CrossRefPubMed Murakami T, Nakazawa G, Horinouchi H, Torii S, Ijichi T, Ohno Y, Amino M, Shinozaki N, Ogata N, Yoshimachi F, Yoshioka K, Ikari Y (2017) Transcatheter closure of atrial septal defect protects from pulmonary edema: septal occluder device gradually reduces LR shunt. Heart Vessels 32:101–104CrossRefPubMed
17.
go back to reference Rich ME, Tseng A, Lim HW, Wang PJ, Su WW (2015) Reduction of iatrogenic atrial septal defects with an anterior and inferior transseptal puncture site when operating the cryoballoon ablation catheter. J Vis Exp 100:e52811 Rich ME, Tseng A, Lim HW, Wang PJ, Su WW (2015) Reduction of iatrogenic atrial septal defects with an anterior and inferior transseptal puncture site when operating the cryoballoon ablation catheter. J Vis Exp 100:e52811
18.
go back to reference Matoshvili Z, Bastani H, Bourke T, Braunschweig F, Drca N, Gudmundsson K, Insulander P, Jemtrén A, Kennebäck G, Saluveer O, Schwieler J, Tapanainen J, Wredlert C, Jensen-Urstad M (2017) Safety of fluoroscopy-guided transseptal approach for ablation of left-sided arrhythmias. Europace 19:2023–2026CrossRefPubMed Matoshvili Z, Bastani H, Bourke T, Braunschweig F, Drca N, Gudmundsson K, Insulander P, Jemtrén A, Kennebäck G, Saluveer O, Schwieler J, Tapanainen J, Wredlert C, Jensen-Urstad M (2017) Safety of fluoroscopy-guided transseptal approach for ablation of left-sided arrhythmias. Europace 19:2023–2026CrossRefPubMed
19.
go back to reference Winkle RA, Mead RH, Engel G, Patrawala RA (2011) The use of a radiofrequency needle improves the safety and efficacy of transseptal puncture for atrial fibrillation ablation. Heart Rhythm 8:1411–1415CrossRefPubMed Winkle RA, Mead RH, Engel G, Patrawala RA (2011) The use of a radiofrequency needle improves the safety and efficacy of transseptal puncture for atrial fibrillation ablation. Heart Rhythm 8:1411–1415CrossRefPubMed
Metadata
Title
Persistence of an iatrogenic atrial septal defect after a second-generation cryoballoon ablation of atrial fibrillation
Authors
Tomonori Watanabe
Shinsuke Miyazaki
Takatsugu Kajiyama
Sadamitsu Ichijo
Takamitsu Takagi
Miyako Igarashi
Hiroaki Nakamura
Hiroshi Taniguchi
Hitoshi Hachiya
Yoshito Iesaka
Publication date
01-09-2018
Publisher
Springer Japan
Published in
Heart and Vessels / Issue 9/2018
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-018-1147-z

Other articles of this Issue 9/2018

Heart and Vessels 9/2018 Go to the issue